Outset Medical Inc

OM.US
Healthcare · Medical Devices
4.72
+0.40 (+9.26%)
USD · NASDAQ

Company Information

Company Name
Outset Medical Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US6901451079
CIK: 0001484612
CUSIP: 690145107
Currency: USD
Full Time Employees: 310
Phone: 669 231 8200
Fiscal Year End: December
IPO Date: Sep 15, 2020
Description:

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Address:

3052 Orchard Drive, San Jose, CA, United States, 95134

People

Directors & Officers

Name Title Year Born
Ms. Leslie L. Trigg President, CEO & Chairman 1971
Ms. Renee M. Gaeta CFO, Principal Financial Officer & Principal Accounting Officer 1981
Mr. John L. Brottem J.D. General Counsel & Secretary 1974
Amelia Merrill VP of People Operations & Culture NA
Dr. Michael Aragon M.D. Chief Medical Officer NA
Dinamarie Stefani Senior Vice President of Regulatory Affairs & Quality Assurance NA
Ms. Brittni McGill Chief Nursing Officer NA
Mr. Brett Fogg Senior Vice President of R&D & Operations NA
Mr. Derick Elliott Executive Vice President of Commercial NA
Mr. Jaime Pulido Senior Vice President of Finance NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 17, 2026 Leslie Trigg N/A Sale 3.36K $3.35 $11.26K
Feb 17, 2026 Marc Nash N/A Sale 1.82K $3.35 $6.09K
Feb 17, 2026 John L Brottem N/A Sale 2.84K $3.35 $9.52K
Jan 21, 2026 John L Brottem N/A Sale 1.18K $5.01 $5.91K
Jan 21, 2026 Leslie Trigg N/A Sale 2.12K $5.05 $10.71K
Jan 21, 2026 Marc Nash N/A Sale 980.00 $4.98 $4.88K
Jan 20, 2026 John L Brottem N/A Sale 9.31K $5.12 $47.69K
Jan 20, 2026 Leslie Trigg N/A Sale 11.79K $5.12 $60.39K
Jan 20, 2026 Marc Nash N/A Sale 5.38K $5.12 $27.52K
Jan 07, 2026 Leslie Trigg N/A Sale 1.80K $4.27 $7.66K
Jan 07, 2026 Marc Nash N/A Sale 108.00 $4.27 $461.16
Jan 07, 2026 John L Brottem N/A Sale 224.00 $4.27 $956.48
Dec 01, 2025 Karen Drexler N/A Sale 1.55K $4.37 $6.76K
Nov 17, 2025 John L Brottem N/A Sale 388.00 $4.60 $1.78K
Nov 17, 2025 Leslie Trigg N/A Sale 916.00 $4.60 $4.21K
Nov 17, 2025 Marc Nash N/A Sale 247.00 $4.60 $1.14K
May 15, 2025 John L Brottem N/A Sale 396.00 $17.82 $7.06K
May 15, 2025 Leslie Trigg N/A Sale 935.00 $17.80 $16.64K
May 15, 2025 Marc Nash N/A Sale 252.00 $17.82 $4.49K
May 15, 2025 Nabeel Ahmed N/A Sale 584.00 $17.81 $10.40K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 2.74M Mar 31, 2026 14.79% $0.00 3.82%
BML Capital Management LLC 1.90M Mar 31, 2026 10.26% $4.69 250.20%
BlackRock Inc 1.26M Mar 31, 2026 6.81% $0.00 -2.02%
Vanguard Group Inc 977.97K Dec 31, 2025 5.28% $0.00 -0.47%
Bank of America Corp 949.40K Mar 31, 2026 5.12% $0.00 -0.12%
Perceptive Advisors LLC 833.33K Mar 31, 2026 4.50% $0.06 0.00%
AQR Capital Management LLC 808.29K Mar 31, 2026 4.36% $0.00 348.14%
Vanguard Capital Management, LLC 763.82K Mar 31, 2026 4.12% $0.00 0.00%
Partner Fund Management LP 594.63K Mar 31, 2026 3.21% $0.21 12.03%
Ensign Peak Advisors Inc 526.59K Mar 31, 2026 2.84% $0.00 -6.00%
Geode Capital Management, LLC 421.37K Mar 31, 2026 2.27% $0.00 5.25%
Assenagon Asset Management SA 339.44K Jun 30, 2026 1.83% $0.00 -32.66%
State Street Corp 334.99K Mar 31, 2026 1.81% $0.00 1.47%
Woodline Partners LP 292.44K Mar 31, 2026 1.58% $0.00 -77.94%
UBS Group AG 252.50K Mar 31, 2026 1.36% $0.00 245.13%
Renaissance Technologies Corp 222.08K Mar 31, 2026 1.20% $0.00 391.26%
Stratos Wealth Partners, LTD 200.55K Mar 31, 2026 1.08% $0.01 0.00%
Morgan Stanley - Brokerage Accounts 169.44K Mar 31, 2026 0.91% $0.00 21.27%
XTX Topco Ltd 142.45K Mar 31, 2026 0.77% $0.01 41.58%
Northern Trust Corp 125.44K Mar 31, 2026 0.68% $0.00 -46.07%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Select Health Care 1.52M 8.20% ▲ 0.00% May 31, 2026
2 Fidelity Advisor Health Care I 800.00K 4.32% ▲ 0.00% May 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 552.83K 2.98% ▲ 0.00% Jun 30, 2026
4 Fidelity VIP Health Care Initial 280.00K 1.51% ▲ 0.00% May 31, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 206.54K 1.11% ▲ 0.00% Jun 30, 2026
6 Fidelity Small Cap Index 165.79K 0.89% ▼ 0.14% Apr 30, 2026
7 Fidelity Extended Market Index 98.66K 0.53% ▲ 0.00% May 31, 2026
8 C WorldWide Healthcare Select 1A 66.67K 0.36% ▲ 0.00% Jun 30, 2026
9 BSF Systematic US Eq Abs Ret A2 USD 61.88K 0.33% ▲ 0.00% Dec 31, 2025
10 iShares Micro-Cap ETF 57.97K 0.31% ▲ 0.00% Jun 30, 2026

Financial Highlights

Market Cap: $80.08M
EBITDA: $-63.39M
Book Value: $6.03
Earnings/Share: $-2.74
Profit Margin: -63.65%
Operating Margin: -60.72%
ROA (TTM): -15.26%
ROE (TTM): -53.17%
Revenue (TTM): $117.59M
Revenue/Share (TTM): $6.52
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -6.30%

Valuation Metrics

Enterprise Value: $19.80M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 18.54M
Shares Float: 15.50M
% Insiders: 507.10%
% Institutions: 8,324.30%
Short % Float: 8.92%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$119.48M
Cost of Goods Sold
adjust
$-72.72M
Gross Profit
subtotal
$46.75M
SG&A
adjust
$-37.86M
R&D
adjust
$-21.24M
Other Operating Expense
adjust
$-54.36M
Operating Income
subtotal
$-66.71M
Other / Non-Operating Items
adjust
$-14.94M
Net Income
subtotal
$-81.65M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about OM.US!